ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia

Chiara Gregorj, Maria R. Ricciardi, Maria T. Petrucci, Maria C. Scerpa, Fabiana De Cave, Paola Fazi, Marco Vignetti, Antonella Vitale, Marco Mancini, Giuseppe Cimino, Salvatore Palmieri, Francesco Di Raimondo, Giorgina Specchia, Francesco Fabbiano, Nicola Cantore, Federico Mosna, Andrea Camera, Mario Luppi, Luciana Annino, Eustachio MiragliaGiuseppe Fioritoni, Francesca Ronco, Giovanna Meloni, Franco Mandelli, Michael Andreeff, Michele Milella, Robin Foà, Agostino Tafuri

Research output: Contribution to journalArticle

Abstract

Extracellular signal-regulated kinase-1/2 (ERK1/2) is frequently found constitutively activated (p-ERK1/2) in hematopoietic diseases, suggesting a role in leukemogenesis. The aim of this study was to assess the expression and clinical role of p-ERK1/2 in adult acute lymphoblastic leukemia (ALL). In 131 primary samples from adult de novo ALL patients enrolled in the Gruppo Italiano per le Malattie Ematologiche dell'Adulto (GIMEMA) Leucemia Acute Linfoide (LAL) 2000 protocol and evaluated by flow cytometry, constitutive ERK1/2 activation was found in 34.5% of cases; these results were significantly associated with higher white blood cell (WBC) values (P = .013). In a multivariate analysis, p-ERK1/2 expression was an independent predictor of complete remission achievement (P = .027). Effective approaches toward MEK inhibition need to be explored in order to evaluate whether this may represent a new therapeutic strategy for adult ALL patients.

Original languageEnglish
Pages (from-to)5473-5476
Number of pages4
JournalBlood
Volume109
Issue number12
DOIs
Publication statusPublished - Jun 15 2007

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia'. Together they form a unique fingerprint.

  • Cite this

    Gregorj, C., Ricciardi, M. R., Petrucci, M. T., Scerpa, M. C., De Cave, F., Fazi, P., Vignetti, M., Vitale, A., Mancini, M., Cimino, G., Palmieri, S., Di Raimondo, F., Specchia, G., Fabbiano, F., Cantore, N., Mosna, F., Camera, A., Luppi, M., Annino, L., ... Tafuri, A. (2007). ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood, 109(12), 5473-5476. https://doi.org/10.1182/blood-2006-05-021071